| 000 | 04620cam a2200529 i 4500 | ||
|---|---|---|---|
| 005 | 20250919005403.0 | ||
| 008 | 150810t20142014vtu b 001 0 eng | ||
| 020 |
_a9781472423573 (hardback : alk. paper) _cRM390.00 |
||
| 020 | _a1472423577 (hardback : alk. paper) | ||
| 020 | _z9781472423580 (ebk - PDF) | ||
| 020 | _z9781472423597 (ebk - ePub) | ||
| 020 | _a1472423593 (electronic bk.) | ||
| 020 | _a1472423585 (electronic bk.) | ||
| 039 | 9 |
_a201511241057 _bzainol _c201510291630 _dfida _c201510291629 _dfida _y08-10-2015 _zfashihah |
|
| 040 |
_aUKM _erda |
||
| 090 | _aQV21.B583p 2014 9 | ||
| 090 |
_aQV21 _b.B583p 2014 9 |
||
| 100 | 1 |
_aBicudo, Edison, _eauthor. |
|
| 245 | 1 | 0 |
_aPharmaceutical research, democracy and conspiracy : _binternational clinical trials in local medical institutions / _cEdison Bicudo, King's College, London, UK. |
| 264 | 1 |
_aFarnham, Surrey, England : _bGower, _c[2014] |
|
| 264 | 4 | _c@2014 | |
| 300 |
_axvi, 175 pages ; _c25 cm |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 0 | _aGower applied research | |
| 504 | _aIncludes bibliographical references (pages 165-171) and index. | ||
| 505 | 0 | _aMachine generated contents note: 0.1.What is a Global Clinical Trial? -- 0.2.What is a CRO? -- 0.3.Multicentre Trials and Social Actions -- 0.4.Aims -- 0.5.Methods, Fieldwork, and Limitations -- 0.6.The Structure of the Book -- 0.7.What is Schrodinger's Cat? -- pt. ONE GLOBAL TRIALS IN MEDICAL INSTITUTIONS -- ch. 1 Infrastructure: The Indirect Privatization of Hospitals -- 1.1.National Regulatory Renewals -- 1.2.The Global Space of Multinational CROs -- 1.3.What are Feasibility Studies? -- 1.4.Criteria to Include or Exclude Sites -- 1.5.What is'n'? -- 1.6.Multicentre Trials and'Systems of Objects' -- 1.7.Multicentre Trials and'Systems of Actions' -- 1.8.Recruitment Partnerships -- 1.9.The Indirect Privatization of Hospitals -- ch. 2 Payments: Global Trials and Local Agreements -- 2.1.Institutional Mechanisms -- 2.2.What is a Research Contract? -- 2.3.What is a Study's Budget? -- 2.4.Hybrid Work -- 2.5.The Dark Side of Research Contracts -- | |
| 505 | 0 | _aContents note continued: 2.6.Global Trials and Local Agreements -- ch. 3 Care: The Global Need for Global Trials -- 3.1.Who are Key Opinion Leaders? -- 3.2.What is a Therapeutic Trial? -- 3.3.Clinical Trials and Medical Decisions -- 3.4.Criteria to Include or Exclude People -- 3.5.Clinical Agreements -- 3.6.Therapy and Care -- 3.7.Global Trials and'Disposable Income' -- 3.8.The Global Need for Global Trials -- pt. TWO GLOBAL TRIALS IN THE GEOGRAPHICAL SPACE -- ch. 4 Communication: The Collective Design of Clinical Protocols -- 4.1.Research Sites and'Communicational Densities' -- 4.2.Clinical Trials in Urban Contexts -- 4.3.The Medical Community -- 4.4.Where do Research Subjects Really Come From? -- 4.5.Global Trials Embedded in Local Contexts -- 4.6.What is a Protocol's Amendment? -- 4.7.The Collective Design of Clinical Protocols -- ch. 5 Globalization: Clinical Trials and International Hierarchies -- 5.1.What are Rescue Countries? -- | |
| 505 | 0 | _aContents note continued: 5.2.Criteria to Include or Exclude Countries -- 5.3.What is Competitive Recruitment? -- 5.4.Clinical Trials and International Hierarchies -- ch. 6 Hope: The Symbolic Dimension of Global Trials -- 6.1.The'Symbolic Efficacy' of Medicines -- 6.2.The Limits of Medicine -- 6.3.How Trustable are Clinical Trials? -- 6.4.Global Trials for Hopeful Patients -- 6.5.Global Trials for Hopeless Hospitals -- 6.6.The Symbolic Dimension of Global Trials -- Conclusion -- Intermediary Groups and Sociology -- Towards a General Theory of Communicative Action -- Global Trials and Institutionalization. | |
| 650 | 2 |
_aDrugs _xTesting _xGovernment policy. |
|
| 650 | 2 |
_aClinical trials _xMoral and ethical aspects. |
|
| 650 | 2 |
_aPharmaceutical industry _xMoral and ethical aspects. |
|
| 650 | 7 |
_aClinical trials _xMoral and ethical aspects. _2fast _0(OCoLC)fst00864436 |
|
| 650 | 7 |
_aDrugs _xTesting _xGovernment policy. _2fast _0(OCoLC)fst00898943 |
|
| 650 | 7 |
_aPharmaceutical industry _xMoral and ethical aspects. _2fast _0(OCoLC)fst01060163 |
|
| 650 | 2 |
_aClinical Trials as Topic _xethics. |
|
| 650 | 2 |
_aDrug Industry _xethics. |
|
| 907 |
_a.b16190397 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV21.B583p 2014 9 |
||
| 914 | _avtls003591420 | ||
| 990 | _azr | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _b2015-10-08 _cm _da _feng _gvtu _y0 _z.b16190397 |
||
| 999 |
_c596810 _d596810 |
||